Richter and Egis sell stakes in Medimpex
Hungary's two leading Hungarian pharmaceutical manufacturers, Richter Gedeon and Egis, have sold their shares in wholesaler Medimpex. The companies each owned a 50% stake, and these are now to be taken over by the leading wholesaler Hungaropharma. Besides pharmacists and another manufacturer, Richter and Egis also own shares in Hungaropharma, reports Patrick Hollstein for ExpoPharm.
With a market share of 7%, Medimpex is the fourth largest wholesaler in Hungary behind Hungaropharma, Phoenix and Humantrade, which belongs to Israeli generics giant Teva. Medimpex owns Pannonmedicina, another wholesaler. According to a representative, the takeover of Medimpex by Hungaropharma has to be seen as an answer to the decreasing sales in the Hungarian pharmaceutical market.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze